We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.44%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$28.3B
AUM Growth
+$2.33B
(+9%)
Cap. Flow
+$1.79B
Cap. Flow
% of AUM
6.32%
Top 10 Holdings %
Top 10 Hldgs %
25.96%
Holding
1,069
New
128
Increased
377
Reduced
389
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$356M |
| 2 |
Lam Research
LRCX
|
+$283M |
| 3 |
Palo Alto Networks
PANW
|
+$261M |
| 4 |
GE Vernova
GEV
|
+$216M |
| 5 |
Tractor Supply
TSCO
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$275M |
| 2 |
Intuit
INTU
|
+$214M |
| 3 |
CrowdStrike
CRWD
|
+$204M |
| 4 |
Williams-Sonoma
WSM
|
+$164M |
| 5 |
Old Dominion Freight Line
ODFL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.61% |
| 2 | Financials | 14.28% |
| 3 | Consumer Discretionary | 13.77% |
| 4 | Industrials | 12.88% |
| 5 | Healthcare | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Flexsteel Industries
FLXS
$317M
| $913K | ﹤0.01% |
16,807
+6,005
| +56% | +$330K |
|
727
Preformed Line Products
PLPC
$1.45B
| $905K | ﹤0.01% |
7,085
| – | – |
|
728
Editas Medicine
EDIT
$402M
| $900K | ﹤0.01% |
708,409
+178,575
| +34% | +$455K |
|
729
Adaptive Biotechnologies
ADPT
$3.6B
| $900K | ﹤0.01% |
150,071
+6,392
| +4% | +$35.2K |
|
730
Lyell Immunopharma
LYEL
$318M
| $887K | ﹤0.01% |
+69,265
| New | +$1.37M |
|
731
Astera Labs
ALAB
$44.6B
| $886K | ﹤0.01% |
+6,690
| New | +$628K |
|
732
Thryv Holdings
THRY
$184M
| $880K | ﹤0.01% |
59,488
+32,211
| +118% | +$508K |
|
733
KLA
KLAC
$249B
| $874K | ﹤0.01% |
13,870
-23,640
| -63% | -$1.6M |
|
|
AHRT
734
AH Realty Trust
AHRT
$540M
| $872K | ﹤0.01% |
85,240
-62
| -0.1% | -$674 |
|
735
iHeartMedia
IHRT
$537M
| $870K | ﹤0.01% |
+439,215
| New | +$930K |
|
736
Lindblad Expeditions
LIND
$1.95B
| $856K | ﹤0.01% |
72,166
-14,958
| -17% | -$172K |
|
737
Prelude Therapeutics
PRLD
$370M
| $850K | ﹤0.01% |
666,574
+491,595
| +281% | +$652K |
|
738
Climb Global Solutions
CLMB
$524M
| $846K | ﹤0.01% |
26,700
-416
| -2% | -$12.4K |
|
739
Birkenstock
BIRK
$7.7B
| $837K | ﹤0.01% |
14,778
+688
| +5% | +$34.9K |
|
740
Primis Financial Corp
FRST
$398M
| $836K | ﹤0.01% |
71,667
-53,944
| -43% | -$648K |
|
741
Xerox
XRX
$360M
| $835K | ﹤0.01% |
+99,012
| New | +$913K |
|
742
W.W. Grainger
GWW
$66B
| $830K | ﹤0.01% |
787
-294
| -27% | -$331K |
|
743
Dell
DELL
$253B
| $829K | ﹤0.01% |
7,190
| – | – |
|
|
LIF
744
Life360
LIF
$4.59B
| $828K | ﹤0.01% |
+20,064
| New | +$883K |
|
745
Eagle Materials
EXP
$6.86B
| $828K | ﹤0.01% |
3,354
-15,184
| -82% | -$4.38M |
|
746
Owens Corning
OC
$11.5B
| $828K | ﹤0.01% |
4,859
+810
| +20% | +$151K |
|
747
PMV Pharmaceuticals
PMVP
$58.7M
| $815K | ﹤0.01% |
539,893
-165,700
| -23% | -$262K |
|
748
Eagle Bancorp
EGBN
$866M
| $807K | ﹤0.01% |
+30,984
| New | +$832K |
|
749
United Therapeutics
UTHR
$26.1B
| $800K | ﹤0.01% |
2,268
| – | – |
|
|
HDSN
750
Hudson Technologies
HDSN
$259M
| $791K | ﹤0.01% |
+141,772
| New | +$934K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2024 Portfolio in Review
As of Q4 2024, Jacobs Levy Equity Management held 1,069 positions worth $28.3B, up 9% from $25.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jacobs Levy Equity Management deployed $1.79B of net new capital in Q4 2024, opening 128 new positions and adding to 377 existing holdings. Its largest new stake was Tractor Supply: 2,947,687 shares worth $156M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Amphenol, an estimated $275M trimmed.
- Jacobs Levy Equity Management's largest Q4 2024 buy was Tractor Supply: 2,947,687 shares worth $156M.
- Jacobs Levy Equity Management added most to Arista Networks in Q4 2024, an estimated $356M increase.
- Jacobs Levy Equity Management's biggest Q4 2024 reduction was Amphenol, cutting an estimated $275M.
- Jacobs Levy Equity Management fully exited Sarepta Therapeutics in Q4 2024, selling an estimated $94.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 26% of its $28.3B portfolio in Q4 2024.
- Jacobs Levy Equity Management opened 128 new positions and closed 143 in Q4 2024.
- Jacobs Levy Equity Management's portfolio value rose 9% quarter-over-quarter to $28.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.